These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8970385)

  • 1. Effects of interleukin-2 and cyclosporin A on pathologic features in Mycoplasma pneumonia.
    Tanaka H; Honma S; Abe S; Tamura H
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1908-12. PubMed ID: 8970385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathological changes by the imbalance of host T helper lymphocyte subsets in Mycoplasma pulmonis pneumonia of mice].
    Tanaka H; Abe S; Tamura H
    Kansenshogaku Zasshi; 1998 Apr; 72(4):342-6. PubMed ID: 9621561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.
    Fonseca-Aten M; Salvatore CM; Mejías A; Ríos AM; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Hardy RD
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4128-36. PubMed ID: 16189089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective immune responses induced by intranasal immunization with Mycoplasma pneumoniae P1C-IL-2 fusion DNA vaccine in mice].
    Zhu C; Yu M; Gao S; Zeng Y; You X; Wu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):585-8. PubMed ID: 23746241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
    Ríos AM; Mejías A; Chávez-Bueno S; Fonseca-Aten M; Katz K; Hatfield J; Gómez AM; Jafri HS; McCracken GH; Ramilo O; Hardy RD
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2897-904. PubMed ID: 15273098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.
    Salvatore CM; Fonseca-Aten M; Katz-Gaynor K; Gomez AM; Mejias A; Somers C; Chavez-Bueno S; McCracken GH; Hardy RD
    Infect Immun; 2007 Jan; 75(1):236-42. PubMed ID: 17074851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effectiveness of prednisolone in Mycoplasma pulmonis-infected pneumonia in mice].
    Tanaka H; Okada H; Yamagishi M; Honma S; Sugawara H; Abe S; Tamura H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Jan; 32(1):42-7. PubMed ID: 8114373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile.
    Hardy RD; Jafri HS; Olsen K; Wordemann M; Hatfield J; Rogers BB; Patel P; Duffy L; Cassell G; McCracken GH; Ramilo O
    Infect Immun; 2001 Jun; 69(6):3869-76. PubMed ID: 11349053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological analysis and pathological examination of gnotobiotic mice monoassociated with Mycoplasma pneumoniae.
    Sekine H; Taguchi H; Watanabe H; Kawai S; Fujioka Y; Goto H; Kobayashi H; Kamiya S
    J Med Microbiol; 2009 Jun; 58(Pt 6):697-705. PubMed ID: 19429744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia.
    Salvatore CM; Fonseca-Aten M; Katz-Gaynor K; Gomez AM; Hardy RD
    Infect Immun; 2008 Feb; 76(2):732-8. PubMed ID: 18039833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycoplasma pulmonis depresses humoral and cell-mediated responses in mice.
    Lai WC; Pakes SP; Owusu I; Wang S
    Lab Anim Sci; 1989 Jan; 39(1):11-5. PubMed ID: 2521910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses in Mycoplasma pneumoniae infection of infant mouse and of man.
    Kanamori M; Katsura T; Ishiyama N; Ogata S; Kitamoto O
    Isr J Med Sci; 1987 Jun; 23(6):568-73. PubMed ID: 3117730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice.
    Fonseca-Aten M; Ríos AM; Mejías A; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Hardy RD
    Am J Respir Cell Mol Biol; 2005 Mar; 32(3):201-10. PubMed ID: 15626776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immune responses in mice induced by intramuscular and intranasal immunization with a Mycoplasma pneumoniae P1C DNA vaccine.
    Zhu C; Wu Y; Chen S; Yu M; Zeng Y; You X; Xiao J; Wang S
    Can J Microbiol; 2012 May; 58(5):644-52. PubMed ID: 22540220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical complications of Mycoplasma pneumoniae disease--central nervous system.
    Ogata S; Kitamoto O
    Yale J Biol Med; 1983; 56(5-6):481-6. PubMed ID: 6433569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.
    Salvatore CM; Techasaensiri C; Tagliabue C; Katz K; Leos N; Gomez AM; McCracken GH; Hardy RD
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1546-51. PubMed ID: 19139287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene expression of tumor necrosis factor-alpha and interferon-gamma in the lungs of Mycoplasma pulmonis-infected mice].
    Nishimoto M
    Nihon Saikingaku Zasshi; 1993 Mar; 48(2):407-15. PubMed ID: 8315807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory properties of Mycoplasma pulmonis. II. Studies on the mechanisms of immunomodulation.
    Romero-Rojas A; Ponce-Hernández C; Mendoza SE; Reyes-Esparza JA; Estrada-Parra S; Hadden JW
    Int Immunopharmacol; 2001 Sep; 1(9-10):1689-97. PubMed ID: 11562061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal model of Mycoplasma pneumoniae infection using germfree mice.
    Hayakawa M; Taguchi H; Kamiya S; Fujioka Y; Watanabe H; Kawai S; Kobayashi H
    Clin Diagn Lab Immunol; 2002 May; 9(3):669-76. PubMed ID: 11986276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DTH effector response and IL-2 are unaffected by cyclosporine A in autoimmune B6D2F1 mice.
    MacLeod H; Goodwin DG; Damphousse C; Lonie E; Xu X; Collins M; Nickerson-Nutter CL
    Cell Immunol; 2010; 266(1):14-23. PubMed ID: 20851384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.